Abstract
Patients with persistent cytopenia are frequently referred to the haematological departments , and a diagnosis of myelodysplastic syndrome is often suspected. After routine assessment including a broad range of blood tests, bone marrow biopsy, and cytogenetics, a definite diagnosis can still not be found for some patients, although they have symptomatic cytopenia. In these cases, next generation sequencing is a valuable supplement in identifying patients with early stages of myeloid cancer.
| Translated title of the contribution | The cause of cytopenia of undetermined significance can often be found by using next generation sequencing |
|---|---|
| Original language | Danish |
| Article number | V03170179 |
| Journal | Ugeskrift for Laeger |
| Volume | 179 |
| Issue number | 25 |
| Number of pages | 4 |
| ISSN | 0041-5782 |
| Publication status | Published - 2017 |
